Perineuronal net degradation in epilepsy

Epilepsia

Volumn 56, Issue 7, 2015, Pages 1124-1133

  Rankin Gee, Elyse K ^a   McRae, Paulette A ^b,c   Baranov, Esther ^b   Rogers, Stephanie ^b   Wandrey, Luke ^b   Porter, Brenda E ^a,b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Aggrecan; Epilepsy; Matrix metalloproteinase; Perineuronal net; Seizure; Status epilepticus

Indexed keywords

AGGRECAN; CHONDROITIN ABC LYASE; MATRIX METALLOPROTEINASE; PARVALBUMIN; PENTETRAZOLE; PILOCARPINE;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; EPILEPSY; EPILEPTIC STATE; EXPERIMENTAL MODEL; HIPPOCAMPUS; INTERNEURON; MALE; MOUSE; MYOCLONUS SEIZURE; NERVE CELL; NONHUMAN; PERINEURONAL NET DEGRADATION; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN DEGRADATION; RAT; SEIZURE SUSCEPTIBILITY; ANIMAL; CHEMICALLY INDUCED; DRUG EFFECTS; NERVE CELL NETWORK; OLIGODENDROGLIA; PATHOLOGY; SPRAGUE DAWLEY RAT;

ANIMALS; HIPPOCAMPUS; MALE; MICE; NERVE NET; OLIGODENDROGLIA; PILOCARPINE; RATS; RATS, SPRAGUE-DAWLEY; STATUS EPILEPTICUS;

EID: 84936764747     PISSN: 00139580     EISSN: 15281167     Source Type: Journal    
DOI: 10.1111/epi.13026     Document Type: Article

References (41)

1. Dityatev A,. Remodeling of extracellular matrix and epileptogenesis. Epilepsia 2010; 51 (Suppl. 3): 61-65.
2. McRae PA, Baranov E, Sarode S, et al., Aggrecan expression, a component of the inhibitory interneuron perineuronal net, is altered following an early-life seizure. Neurobiol Dis 2010; 39: 439-448.
3. McRae PA, Porter BE,. The perineuronal net component of the extracellular matrix in plasticity and epilepsy. Neurochem Int 2012; 61: 963-972.
4. Bruckner G, Brauer K, Hartig W, et al., Perineuronal nets provide a polyanionic, glia-associated form of microenvironment around certain neurons in many parts of the rat brain. Glia 1993; 8: 183-200.
5. Celio MR, Blumcke I,. Perineuronal nets-a specialized form of extracellular matrix in the adult nervous system. Brain Res Rev 1994; 19: 128-145.
6. Frischknecht R, Heine M, Perrais D, et al., Brain extracellular matrix affects AMPA receptor lateral mobility and short-term synaptic plasticity. Nat Neurosci 2009; 12: 897-904.
7. Karetko M, Skangiel-Kramska J,. Diverse functions of perineuronal nets. Acta Neurobiol Exp (Wars) 2009; 69: 564-577.
8. Wang D, Fawcett J,. The perineuronal net and the control of CNS plasticity. Cell Tissue Res 2012; 349: 147-160.
9. Cabungcal JH, Steullet P, Morishita H, et al., Perineuronal nets protect fast-spiking interneurons against oxidative stress. Proc Natl Acad Sci U S A 2013; 110: 9130-9135.
10. Yamaguchi Y,. Lecticans: organizers of the brain extracellular matrix. Cell Mol Life Sci 2000; 57: 276-289.
11. Morawski M, Bruckner G, Arendt T, et al., Aggrecan: beyond cartilage and into the brain. Int J Biochem Cell Biol 2012; 44: 690-693.
12. McRae PA, Rocco MM, Kelly G, et al., Sensory deprivation alters aggrecan and perineuronal net expression in the mouse barrel cortex. J Neurosci 2007; 27: 5405-5413.
13. Galtrey CM, Fawcett JW,. The role of chondroitin sulfate proteoglycans in regeneration and plasticity in the central nervous system. Brain Res Rev 2007; 54: 1-18.
14. Kwok JC, Afshari F, Garcia-Alias G, et al., Proteoglycans in the central nervous system: plasticity, regeneration and their stimulation with chondroitinase ABC. Restor Neurol Neurosci 2008; 26: 131-145.
15. Frischknecht R, Gundelfinger ED,. The brain's extracellular matrix and its role in synaptic plasticity. Adv Exp Med Biol 2012; 970: 153-171.
16. McRae PA, Baranov E, Rogers SL, et al., Persistent decrease in multiple components of the perineuronal net following status epilepticus. Eur J Neurosci 2012; 36: 3471-3482.
17. Sandy JD, Neame PJ, Boynton RE, et al., Catabolism of aggrecan in cartilage explants. Identification of a major cleavage site within the interglobular domain. J Biol Chem 1991; 266: 8683-8685.
18. Arner EC, Hughes CE, Decicco CP, et al., Cytokine-induced cartilage proteoglycan degradation is mediated by aggrecanase. Osteoarthritis Cartilage 1998; 6: 214-228.
19. Mort JS, Buttle DJ,. The use of cleavage site specific antibodies to delineate protein processing and breakdown pathways. Mol Pathol 1999; 52: 11-18.
20. Hughes CE, Caterson B, Fosang AJ, et al., Monoclonal antibodies that specifically recognize neoepitope sequences generated by 'aggrecanase' and matrix metalloproteinase cleavage of aggrecan: application to catabolism in situ and in vitro. Biochem J 1995; 305 (Pt 3): 799-804.
21. Mort JS, Roughley PJ,. Production of antibodies against degradative neoepitopes in aggrecan. Methods Mol Med 2004; 100: 237-250.
22. Fosang AJ, Last K, Stanton H, et al., Neoepitope antibodies against MMP-cleaved and aggrecanase-cleaved aggrecan. Methods Mol Biol 2010; 622: 312-347.
23. Treiman DM, Walton NY, Kendrick C,. A progressive sequence of electroencephalographic changes during generalized convulsive status epilepticus. Epilepsy Res 1990; 5: 49-60.
24. Le Duigou C, Wittner L, Danglot L, et al., Effects of focal injection of kainic acid into the mouse hippocampus in vitro and ex vivo. J Physiol 2005; 569: 833-847.
25. Barbash S, Hanin G, Soreq H,. Stereotactic injection of microRNA-expressing lentiviruses to the mouse hippocampus ca1 region and assessment of the behavioral outcome. J Vis Exp 2013; 76: e50170.
26. Deepa SS, Carulli D, Galtrey C, et al., Composition of perineuronal net extracellular matrix in rat brain: a different disaccharide composition for the net-associated proteoglycans. J Biol Chem 2006; 281: 17789-17800.
27. Struglics A, Hansson M,. MMP proteolysis of the human extracellular matrix protein aggrecan is mainly a process of normal turnover. Biochem J 2012; 446: 213-223.
28. Milev P, Maurel P, Chiba A, et al., Differential regulation of expression of hyaluronan-binding proteoglycans in developing brain: aggrecan, versican, neurocan, and brevican. Biochem Biophys Res Commun 1998; 247: 207-212.
29. Lander C, Kind P, Maleski M, et al., A family of activity-dependent neuronal cell-surface chondroitin sulfate proteoglycans in cat visual cortex. J Neurosci 1997; 17: 1928-1939.
30. Matthews RT, Kelly GM, Zerillo CA, et al., Aggrecan glycoforms contribute to the molecular heterogeneity of perineuronal nets. J Neurosci 2002; 22: 7536-7547.
31. Dino MR, Harroch S, Hockfield S, et al., Monoclonal antibody Cat-315 detects a glycoform of receptor protein tyrosine phosphatase beta/phosphacan early in CNS development that localizes to extrasynaptic sites prior to synapse formation. Neuroscience 2006; 142: 1055-1069.
32. Dwyer CA, Baker E, Hu H, et al., RPTPzeta/phosphacan is abnormally glycosylated in a model of muscle-eye-brain disease lacking functional POMGnT1. Neuroscience 2012; 220: 47-61.
33. Squires RF, Saederup E, Crawley JN, et al., Convulsant potencies of tetrazoles are highly correlated with actions on GABA/benzodiazepine/picrotoxin receptor complexes in brain. Life Sci 1984; 35: 1439-1444.
34. Papp A, Feher O, Erdelyi L,. Properties of the slow inward current induced by pentylenetetrazol in Helix neurons. Epilepsy Res 1990; 6: 119-125.
35. Little CB, Flannery CR, Hughes CE, et al., Aggrecanase versus matrix metalloproteinases in the catabolism of the interglobular domain of aggrecan in vitro. Biochem J 1999; 344 (Pt 1): 61-68.
36. Tsien RY,. Very long-term memories may be stored in the pattern of holes in the perineuronal net. Proc Natl Acad Sci U S A 2013; 110: 12456-12461.
37. Zhang JW, Deb S, Gottschall PE,. Regional and differential expression of gelatinases in rat brain after systemic kainic acid or bicuculline administration. Eur J Neurosci 1998; 10: 3358-3368.
38. Szklarczyk A, Lapinska J, Rylski M, et al., Matrix metalloproteinase-9 undergoes expression and activation during dendritic remodeling in adult hippocampus. J Neurosci 2002; 22: 920-930.
39. Wilczynski GM, Konopacki FA, Wilczek E, et al., Important role of matrix metalloproteinase 9 in epileptogenesis. J Cell Biol 2008; 180: 1021-1035.
40. Nagel S, Sandy JD, Meyding-Lamade U, et al., Focal cerebral ischemia induces changes in both MMP-13 and aggrecan around individual neurons. Brain Res 2005; 1056: 43-50.
41. Pollock E, Everest M, Brown A, et al., Metalloproteinase inhibition prevents inhibitory synapse reorganization and seizure genesis. Neurobiol Dis 2014; 70: 21-31.